CN1137398A - Chinese medicine composite for curing bronchial disease - Google Patents

Chinese medicine composite for curing bronchial disease Download PDF

Info

Publication number
CN1137398A
CN1137398A CN 96100757 CN96100757A CN1137398A CN 1137398 A CN1137398 A CN 1137398A CN 96100757 CN96100757 CN 96100757 CN 96100757 A CN96100757 A CN 96100757A CN 1137398 A CN1137398 A CN 1137398A
Authority
CN
China
Prior art keywords
radix
chinese medicine
grams
disease
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 96100757
Other languages
Chinese (zh)
Other versions
CN1057455C (en
Inventor
师英明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN96100757A priority Critical patent/CN1057455C/en
Publication of CN1137398A publication Critical patent/CN1137398A/en
Application granted granted Critical
Publication of CN1057455C publication Critical patent/CN1057455C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The Chinese medicine composite for curing bronchial disease is composed of ginseng, polygonatum root, cooked rehmannia, Sichuan fritillaria bulb, mulberry root bark, raw liquorice, velvet deerhorn, astragalus root, schisandra berry, earthworm, aster root and frog, etc.. The above-mentioned medicinal materials are respectively pulverized to 20 meshe powders, and mixed according to a certain proportion, then placed in a stainless steel container, low-alcohol white liquor (28 deg.) is added, uniformly stirred, stood still, stirred 30 min each day, after 7 days, the medicated liquor is filtered twice so as to obtain a clear light-yellow liquid, i.e. the invented Chinese medicine composite.

Description

A kind of Chinese medicine composition for the treatment of disease of bronchus
The present invention relates to Chinese medicine, specifically be meant a kind of Chinese medicine composition for the treatment of bronchial asthma, chronic bronchitis.
Bronchial asthma be bronchus under high reactive state because the disease of the popularity airway constriction that Changes in weather or other factors cause, its clinical characters shows as repeatedly expiratory dyspnea outbreak, that have wheezing sound, be a kind of commonly encountered diseases, pilosity is born in child and teenager.Chronic bronchitis is because the bronchial mucosa that infections, chemical factors etc. cause and the chronic inflammatory disease of surrounding tissue thereof, and immunity of organisms lowly reaches autonomic nervous dysfunction to the formation of chronic bronchitis and develop and also play an important role.Clinically with the cough of prolonged and repeated outbreak, cough up phlegm or be feature with panting, primary disease also is a frequently-occurring disease, commonly encountered diseases, prevalence is 3-5% among the crowd, be more common in more than 40 years old in, the old people, the cold district sickness rate is higher.
Western medicine thinks that bronchial asthma, chronic bronchitis all are mainly bronchial pathological change, so the acute attack stages that adopt based on the control infection mitigation symptoms more on clinical treatment, the catabasis is based on two big Therapeutic Principle of health invigorating, disease resistance enhancemen, prevention of recurrence.Usually the method that adopts is:
1, control infection: antibacterial therapy is often selected compound sulfamethoxazole, doxycycline, penicillin, streptomycin or tetracycline, gentamycin, ampicillin etc. for use.
2, medicines such as clinical compound ammonia chloride mixture commonly used of expelling phlegm for arresting cough or bromhexine hydrochloride, potassium iodide, native root syrup.
3, the treatment of relievining asthma: mainly select bronchial spasmolytic agent for use,, also have glucocorticoid medicine such as prednisone, dexamethasone etc. in addition as aminophylline or salbutamol.
Doctor trained in Western medicine is in the treatment of acute attack stage control of seizures, and effect significantly is sure, but thoroughly effects a radical cure above-mentioned two diseases in the catabasis, and this also is that objective fact exists also not have more effective way and ideal medicine at present both at home and abroad.
Motherland's medical science thinks that bronchial asthma, chronic bronchitis belong to Chinese Internal Medicine bronchial wheezing category.Chinese medicine thinks that the lung governing exhalation, kidney governing inspiration, the respiratory function of lung need the improving inspiration by invigorating kidney-QI of kidney to be used for assisting, and has only kidney qi to fill Sheng, the gas of suction can be through respectful the falling of lung and under be contained in kidney.The lung kidney cooperatively interacts and finishes the physiology of respiration activity jointly, so saying of " the lung being the dominator of QI, the kidney being the root of QI " arranged, therefore, Chinese medicine thinks that assertive evidence belongs to deficiency in origin and excess in superficiality, lung kidney with sick." standard card " is meant that the symptom of acute attack stage is promptly coughed, expectorant, breathe heavily, inflammation, main its lung of duty: " assertive evidence " is meant the deficiency syndrome that the catabasis shows, it is the endogenous cause of ill of disease, can be divided into insufficiency of lung-QI, deficiency of spleen-YANG, insufficiency of kidney-YANG, deficiency in both YIN and YANG etc., advocate symptomatic treatment in acute condition clinically, radical treatment in chronic case, give giving consideration to both the incidental and fundamental, strengthening the body resistance treatment, to adjust organism balance, improve immunologic function, reduce the purpose that recurrence reaches thorough healing.
The present invention be according to Chinese medicine to bronchial asthma, chronic bronchitis and complication pathogeny thereof, and through for many years research, a kind of Chinese medicine composition of proposition, this medicine have treating both the principal and secondary aspects of a disease and focus on permanent curing action.
Its composition of Chinese medicine composition provided by the present invention and proportioning are (parts by weight are represented):
Thing part this than (parts by weight) optimum ratio (parts by weight):
Radix Ginseng 3-9 6
Rhizoma Polygonati 40-60 60
Radix Rehmanniae Preparata 9-15 12
Bulbus Fritillariae Cirrhosae 10-50 30
Cortex Mori 10-15 15
Radix Glycyrrhizae 9-15 12
Cornu Cervi Pantotrichum 3-9 6
Radix Astragali 10-30 30
Fructus Schisandrae Chinensis 3-9 6
LUMBRICUS 30-90 60
Radix Asteris 5-15 10
Full frog 50-75 75
The production method of Chinese medicine composition provided by the present invention is:
1, earlier above-mentioned each medicine components is cleaned and crush respectively to granularity be 20 purpose powder;
2, by proportioning that the each component powder is mixed, take by weighing this mixed powder 240-250 gram, place in the rustless steel container, add low alcohol white spirit (28 degree) 700-900 gram, stir, to leave standstill 7 days, stir once every day, about at every turn 30-40 minute;
3, the medicated wine that will soak after seven days filters twice, uses absorbent cotton for the first time, uses the food filter paper for the second time, obtains clarifying weak yellow liquid, and this can treat the medicated wine of bronchial asthma, chronic bronchitis.
The instructions of taking of medicated wine provided by the present invention is: every day twice, acute attack stage is taken 100 grams at every turn, each 50 grams of catabasis, and 30 days is a course of treatment.
This pharmaceutical composition provided by the present invention is a monarch drug with Radix Ginseng, Cornu Cervi Pantotrichum, goes into lung and kidney channel, and the temperature compensating below element improving inspiration by invigorating kidney-QI is returned root, makes under the gas of lung suction to belong to kidney; The Radix Astragali, Fructus Schisandrae Chinensis are gone into lung, spleen channel, the tonifying the lung spleen invigorating, and the convergence QI invigorating is a ministerial drug; Owing to mostly be hot dry property in this Chinese medicine composition, damage cloudy blood easily, and cough with asthma with the passing of time, certainly will undermine cloudy blood, so with Rhizoma Polygonati, Radix Rehmanniae Preparata nourishing the blood and yin, can prevent that again cloudy blood is impaired, confirm that Radix Rehmanniae Preparata has to enrich blood supports smart effect through modern pharmacological research, be used for asthenia of essence and blood, failure of the kidney in receiving QI, the disease of dyspnea and cough due to deficiency of the kidney also is a ministerial drug; Bulbus Fritillariae Cirrhosae, Radix Asteris, Cortex Mori are with going into lung meridian, three medicines mutually 5 have the lung of disappearing, reduce phlegm, the cough-relieving function, LUMBRICUS is returned lung meridian, the tool function of relievining asthma, its alcohol extract can the diastole bronchus reach antihistaminic, and the full frog has function of relieving cough and calming asthma, is used as medicine simultaneously with LUMBRICUS, can strengthen the drug effect of LUMBRICUS, above five kinds of Chinese medicine is an adjuvant drug; The Radix Glycyrrhizae nourishing the lung to arrest cough, the QI invigorating invigorating middle warmer, coordinating the actions of various ingredients in a prescription is a messenger drug.
This Chinese medicine composition is solvent with Chinese liquor, and is refining through medicine is pulverized, soaks, filtered in the preparation process, free from admixture in the medicated wine, and effective component content is more, when taking, borrows the disperse function of wine, and active ingredient can be absorbed rapidly, and produce effects is fast.
This Chinese medicine composition provided by the invention, is marked and this is taken into account simultaneously row and benefit, dry and profit, lung and kidney, and this is why can obtain in the distinguishing feature and the reason for the treatment of bronchial asthma, chronic bronchitis significant curative effect by Chinese medicine composition.Chinese medicine composition of the present invention shows through clinical use:
1, to select pure natural animal and plant Chinese herbal medicine for use be raw material to this product, and each component meets the pharmaceutical control law regulation, utilizes the comprehensive function of the Chinese medicine of respectively distinguishing the flavor of and the treatment of coordinative role each other bronchial asthma, chronic bronchitis, do not contain any hormone, nontoxic to human body.
2, this product need not decoct, taking convenience, and all can with clothes ante cibum after meal or with meal.
3, this product can increase the expiration peak flow rate value of asthmatic patient significantly, and the stronger expansion bronchus smooth muscle and the effect of pulmonary ventilation function improving are arranged.
4, the patient used separately in the catabasis, can unite use with other Western medicine at acute attack stage, but can significantly reduce the conventional amount used of above-mentioned Western medicine, shorten the course of treatment, therapeutic effect obviously increases, and can alleviate or eliminate other complication, the immunity of enhancing body significantly.
5, for concurrent obstructive emphysema, bronchiectasic patient, use medicine may command of the present invention and infect, mitigation symptoms, health invigorating, disease resistance enhancemen prevents that pulmonary function from worsening.
Use Chinese medicine composition of the present invention, treatment bronchial asthma 16 examples, total effective rate 96%, treatment chronic bronchitis 11 examples, total effective rate 88%.
Embodiment 1:
Select following component for use by proportioning: Radix Ginseng 30 grams, Rhizoma Polygonati 400 grams, Radix Rehmanniae Preparata 90 grams, Bulbus Fritillariae Cirrhosae 100 grams, Cortex Mori 100 grams, Radix Glycyrrhizae 90 grams, Cornu Cervi Pantotrichum 30 grams, the Radix Astragali 100 grams, Fructus Schisandrae Chinensis 30 grams, LUMBRICUS 300 grams, Radix Asteris 50 grams, the full frog 500 grams; Be 20 purpose powder with above-mentioned each medicine components pulverize separately to granularity earlier, by proportioning that the each component powder is mixed, take by weighing this mixed powder 240 grams, place in the rustless steel container, add low alcohol white spirit (28 degree) 700 grams, stir, left standstill 7 days, stir once every day, each about 30 minutes, the medicated wine of immersion after seven days is filtered twice, use absorbent cotton for the first time, for the second time use the food filter paper, obtain clarifying weak yellow liquid.
Embodiment 2:
Select following component for use by proportioning: Radix Ginseng 90 grams, Rhizoma Polygonati 600 grams, Radix Rehmanniae Preparata 150 grams, Bulbus Fritillariae Cirrhosae 500 grams, Cortex Mori 150 grams, Radix Glycyrrhizae 150 grams, Cornu Cervi Pantotrichum 90 grams, the Radix Astragali 300 grams, Fructus Schisandrae Chinensis 90 grams, LUMBRICUS 900 grams, Radix Asteris 150 grams, the full frog 750 grams; Be 20 purpose powder with above-mentioned each medicine components pulverize separately to granularity earlier, by proportioning that the each component powder is mixed, take by weighing this mixed powder 250 grams, place in the rustless steel container, add low alcohol white spirit (28 degree) 800 grams, stir, left standstill 7 days, stir once every day, each about 40 minutes, the medicated wine of immersion after seven days is filtered twice, use absorbent cotton for the first time, for the second time use the food filter paper, obtain clarifying weak yellow liquid.
Embodiment 3:
Select following component for use by proportioning: Radix Ginseng 60 grams, Rhizoma Polygonati 600 grams, Radix Rehmanniae Preparata 120 grams, Bulbus Fritillariae Cirrhosae 300 grams, Cortex Mori 150 grams, Radix Glycyrrhizae 120 grams, Cornu Cervi Pantotrichum 60 grams, the Radix Astragali 300 grams, Fructus Schisandrae Chinensis 60 grams, LUMBRICUS 600 grams, Radix Asteris 100 grams, the full frog 750 grams; Be 20 purpose powder with above-mentioned each medicine components pulverize separately to granularity earlier, by proportioning that the each component powder is mixed, take by weighing this mixed powder 250 grams, place in the rustless steel container, add low alcohol white spirit (28 degree) 800 grams, stir, left standstill 7 days, stir once every day, each about 40 minutes, the medicated wine of immersion after seven days is filtered twice, use absorbent cotton for the first time, for the second time use the food filter paper, obtain clarifying weak yellow liquid.

Claims (3)

1, a kind of Chinese medicine composition for the treatment of disease of bronchus wherein, comprises following component:
Thing part proportioning (parts by weight)
Radix Ginseng 3-9,
Rhizoma Polygonati 40-60,
Radix Rehmanniae Preparata 9-15,
Bulbus Fritillariae Cirrhosae 10-50,
Cortex Mori 10-15,
Radix Glycyrrhizae 9-15,
Cornu Cervi Pantotrichum 3-9,
Radix Astragali 10-30,
Fructus Schisandrae Chinensis 3-9,
LUMBRICUS 30-90,
Radix Asteris 5-15,
Full frog 50-75.
2, the described a kind of Chinese medicine composition for the treatment of disease of bronchus of claim 1 wherein, comprises following component:
Thing part proportioning (parts by weight)
Radix Ginseng 6,
Rhizoma Polygonati 60,
Radix Rehmanniae Preparata 12,
Bulbus Fritillariae Cirrhosae 30,
Cortex Mori 15,
Radix Glycyrrhizae 12,
Cornu Cervi Pantotrichum 6,
The Radix Astragali 30,
Fructus Schisandrae Chinensis 6,
LUMBRICUS 60,
Radix Asteris 10,
The full frog 75.
3, the described a kind of Chinese medicine composition for the treatment of disease of bronchus of claim 1, wherein, production method is:
(1), earlier granularity is cleaned, is crushed to above-mentioned each medicine components respectively is 20 purpose powder;
(2), by proportioning that the each component powder is mixed, take by weighing this mixed powder, place in the rustless steel container, add the low alcohol white spirit of treble amount, stir, leave standstill a couple of days, stir once every day, about at every turn 30-40 minute;
(3), the medicated wine after will soaking filters twice, use absorbent cotton for the first time, use the food filter paper second time, obtains clarifying weak yellow liquid.
CN96100757A 1996-02-02 1996-02-02 Chinese medicine composite for curing bronchial disease Expired - Fee Related CN1057455C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN96100757A CN1057455C (en) 1996-02-02 1996-02-02 Chinese medicine composite for curing bronchial disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN96100757A CN1057455C (en) 1996-02-02 1996-02-02 Chinese medicine composite for curing bronchial disease

Publications (2)

Publication Number Publication Date
CN1137398A true CN1137398A (en) 1996-12-11
CN1057455C CN1057455C (en) 2000-10-18

Family

ID=5116723

Family Applications (1)

Application Number Title Priority Date Filing Date
CN96100757A Expired - Fee Related CN1057455C (en) 1996-02-02 1996-02-02 Chinese medicine composite for curing bronchial disease

Country Status (1)

Country Link
CN (1) CN1057455C (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102188451A (en) * 2010-03-04 2011-09-21 何国增 Lumbricus kwangtungensis preparation for bronchial asthma disease
CN103861016A (en) * 2014-04-04 2014-06-18 刘作功 Drug for treating allergic asthma

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102188451A (en) * 2010-03-04 2011-09-21 何国增 Lumbricus kwangtungensis preparation for bronchial asthma disease
CN103861016A (en) * 2014-04-04 2014-06-18 刘作功 Drug for treating allergic asthma

Also Published As

Publication number Publication date
CN1057455C (en) 2000-10-18

Similar Documents

Publication Publication Date Title
CN1201767C (en) Chinese medicine composition for treating asthma and preparation method thereof
CN102526674A (en) Medicine for treating bronchitis and bronchial asthma suffered by children aging from three to seven
CN103520413A (en) Chinese medicament for treating asthma
CN107050338A (en) Chinese medicine composition and preparation method for treating chronic pharyngitis
CN100512860C (en) Medicine for preventing and controlling chicken infectious laryngotracheitis
CN101485834B (en) Chinese medicine for treating diabetes
CN1201793C (en) Medicine composition for treatment of cough and asthma and preparation thereof
CN111467459B (en) Traditional Chinese medicine composition for treating novel coronavirus pneumonia at recovery stage, application and preparation method thereof
CN101066394A (en) Externally applied medicine for treating infantile pneumonitis, bronchitis and asthma
CN101249208B (en) Proprietary Chinese medicine preparations for curing chronic emphraxis lung diseases
CN1057455C (en) Chinese medicine composite for curing bronchial disease
CN102188568B (en) Externally applied traditional Chinese medicine powder for treating cold
CN104225126A (en) Phlegm dissolving and cough quenching paste
CN100364587C (en) Acupoint selection strapping medicine for treating chronic bronchitis and bronchial asthma and its compounding method
WO2021103777A1 (en) Spraying agent for preventing and treating allergic asthma combined with allergic rhinitis in children and teenagers
CN1338268A (en) Anticough lung-moistening jelly and its preparing process
CN104353045A (en) Walnut cream with asthma preventing effect
CN1706467A (en) Plaster for treating bronchitis
CN104367975A (en) Flos farfarae paste for relieving cough and eliminating phlegm
CN107582834A (en) A kind of Chinese medicine composition for treating empty asthma
CN115531513B (en) Traditional Chinese medicine preparation for treating adult snoring and preparation method thereof
CN114984166B (en) New coronaries pneumonia rehabilitation traditional Chinese medicine composition and application thereof
CN107296906A (en) Chinese medicine composition and its application in pneumonia treatment
CN111265638A (en) Traditional Chinese medicine application for treating child anorexia and preparation method thereof
CN1060662C (en) Foot-washing antitussive lotion and its preparing method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee